Certara Announces CFO Transition
Certara, a leader in model-informed drug development, announced that CFO John Gallagher will resign effective July 14, 2026. Faiz Mohammed, Senior VP of Finance, will serve as interim CFO during the transition. The company has initiated a search for a permanent replacement and reaffirmed its 2026 financial guidance.